Development of a seven-gene tumor immune microenvironment prognostic signature for high-risk grade III endometrial cancer
Uterine corpus endometrial carcinoma locally infiltrates numerous immune cells and other tumor immune microenvironment components. These cells are involved in malignant tumor growth and proliferation and the process of resistance toward immunotherapies. Here, we aimed to develop a tumor immune micro...
Main Authors: | Mingjun Zheng, Yuexin Hu, Rui Gou, Siting Li, Xin Nie, Xiao Li, Bei Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-09-01
|
Series: | Molecular Therapy: Oncolytics |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2372770521000978 |
Similar Items
-
Identification of a Novel Tumor Microenvironment Prognostic Signature for Advanced-Stage Serous Ovarian Cancer
by: Mingjun Zheng, et al.
Published: (2021-07-01) -
Identification of Tumor Microenvironment-Related Alternative Splicing Events to Predict the Prognosis of Endometrial Cancer
by: Xuan Liu, et al.
Published: (2021-04-01) -
A Novel Transcription Factor-Based Prognostic Signature in Endometrial Cancer: Establishment and Validation
by: Yang X, et al.
Published: (2021-04-01) -
A Novel Prognostic Model of Endometrial Carcinoma Based on Clinical Variables and Oncogenomic Gene Signature
by: Fang Deng, et al.
Published: (2021-01-01) -
Novel immune-related genes in the tumor microenvironment with prognostic value in breast cancer
by: Wen Tan, et al.
Published: (2021-02-01)